[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Biochemistry](https://durgical.com/en/biochemistry/) › Lysosomal ganglioside breakdown [Biochemistry](https://durgical.com/en/biochemistry/) · Metabolic pathway # Lysosomal ganglioside breakdown Lysosomes take gangliosides apart one piece at a time, down to sphingosine. A missing enzyme at any step causes a storage disease. Updated 2026-11-01 ## Interactive map ## Key facts - Each step removes the outermost sugar (or, at the end, the fatty acid) and needs the step before it: the order is strict. - GM2 → GM3 needs hexosaminidase A plus the GM2 activator protein; their loss causes Tay–Sachs disease and its variants. - Glucocerebrosidase turns glucosylceramide into ceramide; its deficiency, Gaucher disease, is the most common lysosomal storage disease. - Acid ceramidase deficiency (Farber disease) gives a hoarse cry, painful swollen joints and nodules under the skin. - Saposins (sphingolipid activator proteins) help most of these hydrolases reach their lipid substrates. **Also called** Sphingolipid degradation ## Regulation - These enzymes are not under hormonal control; flux depends on how much lipid arrives by endocytosis and autophagy. - The transcription factor TFEB raises the whole set of lysosomal enzymes when lysosomes are under stress. - Mannose-6-phosphate tags send the enzymes to the lysosome; without them (I-cell disease) all are missing from it. ## The steps, one by one - **Step 1 · Acid β-galactosidase (GLB1)** irreversible GM1 ganglioside + H₂O → [gm2_ganglioside](https://durgical.com/en/biochemistry/molecules/gm2-ganglioside/) + [Galactose](https://durgical.com/en/biochemistry/molecules/galactose/) Removes the terminal galactose of GM1, leaving GM2. **If it fails:** GM1 gangliosidosis: neurodegeneration, cherry-red spot, enlarged liver and spleen and bone changes in the infantile form. [GM1 gangliosidosis →](https://durgical.com/en/conditions/gm1-gangliosidosis/) - **Step 2 · [β-Hexosaminidase A (HEXA α + HEXB β subunits) with the GM2 activator](https://durgical.com/en/biochemistry/enzymes/hexosaminidase-a/)** irreversible [gm2_ganglioside](https://durgical.com/en/biochemistry/molecules/gm2-ganglioside/) + H₂O → GM3 ganglioside + N-Acetylgalactosamine Cuts off N-acetylgalactosamine; only the αβ form (Hex A), helped by the GM2 activator protein, can reach GM2. **If it fails:** Tay–Sachs (HEXA): GM2 fills neurons, with a cherry-red spot and no organ enlargement; Sandhoff (HEXB) also loses Hex B and adds visceral signs. [Tay–Sachs disease →](https://durgical.com/en/conditions/tay-sachs-disease/) - **Step 3 · Lysosomal sialidase (neuraminidase; NEU1, NEU4)** irreversible GM3 ganglioside + H₂O → Lactosylceramide + Sialic acid (NANA) Removes the sialic acid (N-acetylneuraminic acid) that makes a lipid a ganglioside, leaving the neutral lactosylceramide. **If it fails:** NEU1 deficiency causes sialidosis, with cherry-red spot and myoclonus; it mainly stores sialylated glycoproteins rather than GM3. - **Step 4 · β-Galactosidase (galactocerebrosidase GALC or GLB1) with saposins** irreversible Lactosylceramide + H₂O → [Glucosylceramide](https://durgical.com/en/biochemistry/molecules/glucosylceramide/) + [Galactose](https://durgical.com/en/biochemistry/molecules/galactose/) Removes galactose from lactosylceramide, leaving glucosylceramide; galactocerebrosidase and GM1 β-galactosidase can both do it. **If it fails:** Fabry disease joins here: without α-galactosidase A, globotriaosylceramide cannot be trimmed to lactosylceramide and builds up in vessels, kidney and heart. [Fabry disease →](https://durgical.com/en/conditions/fabry-disease/) - **Step 5 · [Glucocerebrosidase (acid β-glucosidase, GBA1)](https://durgical.com/en/biochemistry/enzymes/glucocerebrosidase/)** irreversible [Glucosylceramide](https://durgical.com/en/biochemistry/molecules/glucosylceramide/) + H₂O → [Ceramide](https://durgical.com/en/biochemistry/molecules/ceramide/) + [Glucose](https://durgical.com/en/biochemistry/molecules/glucose/) Removes the glucose from glucosylceramide, with help from saposin C, leaving ceramide. **If it fails:** Gaucher disease: glucosylceramide fills macrophages (Gaucher cells) in spleen, liver and bone marrow; GBA1 variants also raise the risk of Parkinson disease. [Gaucher disease →](https://durgical.com/en/conditions/gaucher-disease/) - **Step 6 · Acid ceramidase (ASAH1)** irreversible [Ceramide](https://durgical.com/en/biochemistry/molecules/ceramide/) + H₂O → [Sphingosine](https://durgical.com/en/biochemistry/molecules/sphingosine/) + Fatty acid Splits the amide bond of ceramide into sphingosine and a fatty acid, which leave the lysosome to be reused. **If it fails:** Farber disease: ceramide builds up in joints, larynx and skin, with nodules, swollen joints and a hoarse cry. Ceramide also arrives from sphingomyelin (Niemann–Pick), galactosylceramide (Krabbe) and sulfatide (metachromatic leukodystrophy). [Farber disease (Farber lipogranulomatosis) →](https://durgical.com/en/conditions/farber-disease/) ## Clinical notes - Cherry-red spot in the macula: Tay–Sachs, Sandhoff, GM1 gangliosidosis and Niemann–Pick type A. - Enzyme replacement exists for Gaucher and Fabry disease; substrate reduction (eliglustat, miglustat) slows glucosylceramide synthesis. - Side branches join this line: Fabry (α-galactosidase A), Krabbe (galactocerebrosidase), metachromatic leukodystrophy (arylsulfatase A) and Niemann–Pick (sphingomyelinase). - Most are autosomal recessive; Fabry disease is X-linked. ## Pathways - [Lysosomal ganglioside breakdown](https://durgical.com/en/biochemistry/pathways/lysosomal-ganglioside-breakdown/) ## Related conditions - [GM1 gangliosidosis](https://durgical.com/en/conditions/gm1-gangliosidosis/) - [Tay–Sachs disease](https://durgical.com/en/conditions/tay-sachs-disease/) - [Fabry disease](https://durgical.com/en/conditions/fabry-disease/) - [Gaucher disease](https://durgical.com/en/conditions/gaucher-disease/) - [Farber disease (Farber lipogranulomatosis)](https://durgical.com/en/conditions/farber-disease/) - [Niemann–Pick disease](https://durgical.com/en/conditions/niemann-pick-disease/) - [Krabbe disease (globoid cell leukodystrophy)](https://durgical.com/en/conditions/krabbe-disease/) - [Metachromatic leukodystrophy](https://durgical.com/en/conditions/metachromatic-leukodystrophy/) ## Related - [GM2 ganglioside](https://durgical.com/en/biochemistry/molecules/gm2-ganglioside/) - [Glucosylceramide (glucocerebroside)](https://durgical.com/en/biochemistry/molecules/glucosylceramide/) - [Ceramide](https://durgical.com/en/biochemistry/molecules/ceramide/) - [Sphingosine](https://durgical.com/en/biochemistry/molecules/sphingosine/) - [Hexosaminidase A (β-hexosaminidase A)](https://durgical.com/en/biochemistry/enzymes/hexosaminidase-a/) - [Glucocerebrosidase (acid β-glucosidase)](https://durgical.com/en/biochemistry/enzymes/glucocerebrosidase/) - [α-Galactosidase A](https://durgical.com/en/biochemistry/enzymes/galactosidase-a/) - [Acid sphingomyelinase](https://durgical.com/en/biochemistry/enzymes/acid-sphingomyelinase/) - [Galactosylceramide (galactocerebroside)](https://durgical.com/en/biochemistry/molecules/galactosylceramide/) - [Sulfatide](https://durgical.com/en/biochemistry/molecules/sulfatide/) - [Sphingomyelin](https://durgical.com/en/biochemistry/molecules/sphingomyelin/) - [Sphingolipids and sphingolipidoses](https://durgical.com/en/biochemistry/topics/sphingolipids-and-sphingolipidoses/) - [Lysosomal storage diseases](https://durgical.com/en/biochemistry/topics/lysosomal-storage-diseases/) - [Mannose 6-phosphate tagging (sending enzymes to the lysosome)](https://durgical.com/en/biochemistry/topics/mannose-6-phosphate-tagging/) ## Test yourself Think of the answer, then tap the question to see it. ## Which enzyme is missing in Tay–Sachs disease, and which lipid accumulates? Hexosaminidase A (HEXA gene); GM2 ganglioside accumulates in neurons. ## Which step fails in Gaucher disease? Glucocerebrosidase cannot turn glucosylceramide into ceramide, so glucosylceramide fills macrophages. ## What are the three classic signs of Farber disease? A hoarse voice or weak cry, nodules under the skin (lipogranulomas) and painful swollen joints, from ceramide build-up. ## Which lysosomal disease of this pathway is X-linked? Fabry disease (α-galactosidase A); the others in this pathway are autosomal recessive. [Add to my cards (4)](https://durgical.app/estudiar/?add=/en/biochemistry/pathways/lysosomal-ganglioside-breakdown/) Educational information, not medical advice. For any symptom, see a health professional. Sources: [Tay-Sachs disease: MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/tay-sachs-disease/) (MedlinePlus, US National Library of Medicine, 2026); [Gaucher disease: MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/gaucher-disease/) (MedlinePlus, US National Library of Medicine, 2026); [Farber lipogranulomatosis: MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/farber-lipogranulomatosis/) (MedlinePlus, US National Library of Medicine, 2026); [GM1 gangliosidosis: MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/gm1-gangliosidosis/) (MedlinePlus, US National Library of Medicine, 2026); [Sialidosis: MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/sialidosis/) (MedlinePlus, US National Library of Medicine, 2026); Textbook of Biochemistry for Medical Students, 6th ed. (Jaypee Brothers Medical Publishers (Vasudevan DM, Sreekumari S, Vaidyanathan K), 2011). [← All of biochemistry](https://durgical.com/en/biochemistry/) ## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake Representative model, for educational purposes only. --- Source: https://durgical.com/en/biochemistry/pathways/lysosomal-ganglioside-breakdown/ License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/biochemistry/pathways/lysosomal-ganglioside-breakdown/